Staggering the dose of sugammadex lowers risks for severe emergence cough: A randomized control trial
BMC Anesthesiology Oct 27, 2017
Loh PS, et al. - Cough on emergence has been reported as a common adverse reaction with sugammadex reversal. This single-center, randomized, double-blinded study was implemented to find out whether staggering the dose of sugammadex will reduce emergence cough. As per findings, this dosing strategy will effectively decrease common emergence and early postoperative complications.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries